Nuo Therapeutics, Inc. 8-K Filing
Ticker: AURX · Form: 8-K · Filed: Dec 17, 2025 · CIK: 1091596
| Field | Detail |
|---|---|
| Company | Nuo Therapeutics, Inc. (AURX) |
| Form Type | 8-K |
| Filed Date | Dec 17, 2025 |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Nuo Therapeutics, Inc. (ticker: AURX) to the SEC on Dec 17, 2025.
How long is this filing?
Nuo Therapeutics, Inc.'s 8-K filing is 2 pages with approximately 514 words. Estimated reading time is 2 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 514 words · 2 min read · ~2 pages · Grade level 12.1 · Accepted 2025-12-17 11:09:26
Filing Documents
- aurx20251216c_8k.htm (8-K) — 40KB
- 0001437749-25-038091.txt ( ) — 156KB
- aurx-20251216.xsd (EX-101.SCH) — 3KB
- aurx-20251216_def.xml (EX-101.DEF) — 10KB
- aurx-20251216_lab.xml (EX-101.LAB) — 14KB
- aurx-20251216_pre.xml (EX-101.PRE) — 10KB
- aurx20251216c_8k_htm.xml (XML) — 3KB
07 Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders. On December 16, 2025, Nuo Therapeutics, Inc. (the "Company") held its 2025 Annual Meeting of Stockholders. The following matters were considered and voted upon: 1. To elect four directors to serve on the Company's Board of Directors, each to serve until the Company's next annual meeting of stockholders or until each successor is duly elected and qualified; 2. To ratify the appointment of MaloneBailey LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025; 3. To approve, on an advisory basis, the compensation of the Company's named executive officers. The results of the vote were as follows: 1. Election of Directors For Withheld Broker Non-Votes David E. Jorden 33,688,602 4,962 2,237,142 Paul D. Mintz 33,686,279 7,285 2,237,142 Scott M. Pittman 33,686,279 7,285 2,237,142 C. Eric Winzer 33,658,723 34,841 2,237,142 For Against Abstain Broker Non-Votes 2. To ratify the appointment of MaloneBailey LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 35,917,807 12,899 0 0 For Against Abstain Broker Non-Votes 3. To approve, on an advisory basis, the compensation of the Company's named executive officers 33,653,458 40,106 0 2,237,142
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Nuo Therapeutics, Inc. By: /s/ David E. Jorden David E. Jorden Chief Executive and Chief Financial Officer Date: December 17, 2025